Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients (Q38941319)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

title

Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

main subject

lung cancer

1 reference

based on heuristic

inferred from title

author name string

Song Xu

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Feng Lou

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Yi Wu

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Da-Qiang Sun

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Jing-Bo Zhang

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Wei Chen

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Hua Ye

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Jing-Hao Liu

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Sen Wei

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Ming-Yu Zhao

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Wen-Jun Wu

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Xue-Xia Su

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Rong Shi

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Lindsey Jones

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Xue F Huang

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Si-Yi Chen

series ordinal

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

Jun Chen

series ordinal

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

language of work or name

English

0 references

publication date

12 November 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

published in

Cancer Letters

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

volume

370

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

page(s)

324-331

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

cites work

Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by ion torrent DNA sequencing

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-free nucleic acids as biomarkers in cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumor heterogeneity: seeing the wood for the trees.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of circulating tumor DNA in early- and late-stage human malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of free circulating DNA as a diagnostic marker in lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer heterogeneity: implications for targeted therapeutics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent KIT mutations in human gastrointestinal stromal tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The origin and mechanism of circulating DNA

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26582655

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.CANLET.2015.11.005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

PMC publication ID

7495502

0 references

PubMed publication ID

26582655

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26582655

retrieved

7 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38941319&oldid=1797416076"